Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Small cell lung cancer.

Sher T, Dy GK, Adjei AA.

Mayo Clin Proc. 2008 Mar;83(3):355-67. doi: 10.4065/83.3.355. Review.

PMID:
18316005
3.

Combined modality therapy of lung cancer.

Livingston RB.

Clin Cancer Res. 1997 Dec;3(12 Pt 2):2638-47. Review.

4.

Management of small cell cancer of the lung.

Adjei AA.

Curr Opin Pulm Med. 2000 Jul;6(4):384-90. Review.

PMID:
10912650
5.

Modern management of small-cell lung cancer.

Ferraldeschi R, Baka S, Jyoti B, Faivre-Finn C, Thatcher N, Lorigan P.

Drugs. 2007;67(15):2135-52. Review.

PMID:
17927281
6.

Mid-course thoracic radiotherapy with cisplatin-etoposide chemotherapy in limited-stage small-cell lung cancer.

Akyurek S, Onal C, Cagar A, Hicsonmez A, Andrieu MN, Kurtman C.

Med Oncol. 2006;23(4):499-505.

PMID:
17303908
7.

Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small-cell carcinoma of the lung.

Murray N, Shah A, Brown E, Kostashuk E, Laukkanen E, Goldie J, Band P, Van den Hoek J, Murphy K, Sparling T, et al.

Semin Oncol. 1986 Sep;13(3 Suppl 3):24-30.

PMID:
3020695
8.

Management of small cell lung cancer.

Ciombor KK, Rocha Lima CM.

Curr Treat Options Oncol. 2006 Jan;7(1):59-68. Review.

PMID:
16343369
9.

[Small cell lung cancer--state of the art and future perspectives].

J Barata F, Costa AF.

Rev Port Pneumol. 2007 Jul-Aug;13(4):587-604. Review. Portuguese.

PMID:
17898914
10.

Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.

Spiro SG, James LE, Rudd RM, Trask CW, Tobias JS, Snee M, Gilligan D, Murray PA, Ruiz de Elvira MC, O'Donnell KM, Gower NH, Harper PG, Hackshaw AK; London Lung Cancer Group.

J Clin Oncol. 2006 Aug 20;24(24):3823-30.

PMID:
16921033
11.

Limited-stage small-cell lung cancer: the current status of combined-modality therapy.

Socinski MA, Bogart JA.

J Clin Oncol. 2007 Sep 10;25(26):4137-45. Review.

PMID:
17827464
12.

[Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].

Payne DG, Murray N, Warde P.

Bull Cancer. 1994 Feb;81(2):119-28. French.

PMID:
7894117
13.

Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer.

Laurie SA, Logan D, Markman BR, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

Lung Cancer. 2004 Feb;43(2):223-40.

PMID:
14739044
14.

Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, Posner JB, Dalmau J.

Brain. 1997 Aug;120 ( Pt 8):1279-300.

PMID:
9278623
15.

Chemoradiotherapy for lung cancer: current status and perspectives.

Ohe Y.

Int J Clin Oncol. 2004 Dec;9(6):435-43. Review.

PMID:
15616873
16.

Intensive combined modality therapy for limited-stage small-cell lung cancer.

Elias AD, Ayash L, Frei E 3rd, Skarin AT, Hunt M, Wheeler C, Schwartz G, Mazanet R, Tepler I, Eder JP, et al.

J Natl Cancer Inst. 1993 Apr 7;85(7):559-66.

PMID:
8384264
17.

Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).

Schild SE, Bonner JA, Hillman S, Kozelsky TF, Vigliotti AP, Marks RS, Graham DL, Soori GS, Kugler JW, Tenglin RC, Wender DB, Adjei A.

J Clin Oncol. 2007 Jul 20;25(21):3124-9.

PMID:
17634491
18.

[Lambert-Eaton myasthenic syndrome with acute respiratory failure associated with small cell lung cancer].

Brueck M, Vogel S, Waeger S, Braig G, Kramer W.

Dtsch Med Wochenschr. 2004 Jan 30;129(5):193-6. German.

PMID:
14735416
19.
20.

Management of small cell lung cancer.

Johnson BE.

Clin Chest Med. 2002 Mar;23(1):225-39. Review.

PMID:
11901913

Supplemental Content

Support Center